We were delighted to talk with Professor Elisabeth Bendstrup (Aarhus University Hospital, Denmark) around the barriers and latest advances in treating interstitial lung disease.
Questions
- What are the barriers to the early diagnosis of interstitial lung disease (ILD)? (0:18)
- What are the hot topics and latest research you are looking forward to exploring in ILD during 2021? (2:05)
Disclosures: Elisabeth Bendstrup has received grants or personal fees for talks, advisory board meetings, travel support for conferences and meetings from Boehringer Ingelheim, Roche, AStraZeneca, Galapagos, Bristol Myers Squibb in recent years.
Support:Â Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ERS 2021 (Virtual).
